Posts for Voyager Therapeutics, Inc. ($VYGR)

Showing 1 - 2 of 2 Posts

Last updated: 21 days ago

Novo Nordisk's Comeback: The Battle for Weight-Loss Market Dominance

Explore Novo Nordisk's rebound in the weight-loss sector amid competition from Eli Lilly, Pfizer, and others. Key insights for investors in the evolving landscape of obesity treatments.

Novo Nordisk Weight Loss GLP-1 Drugs Eli Lilly Market Trends

Voyager Therapeutics 8-K Report: Key Insights & SEC Compliance Overview

$VYGR

•

Form 8-K

•

2025-02-11

Last updated: 8 months ago

Voyager Therapeutics 8-K Report: Key Insights & SEC Compliance Overview

Explore Voyager Therapeutics' 8-K report filed on February 11, 2025. Key insights on compliance, stock details, and financial measurements in USD.

Voyager Therapeutics biotechnology NASDAQ financial reporting 8-K filing